Abstract
Plasma biomarkers have been investigated in the Alzheimer's disease (AD) continuum as they were considered as a non-invasive and economical alternative for early diagnosis. Due to the high and growing incidence of dementia in the world, there is a great need to understand the relationship between blood biomarkers and other biomarkers of Alzheimer's disease (AD), such as neuroimaging, for …